Sprintome
@sprintome
Followers
4
Following
10
Media
51
Statuses
165
AI + Drug Discovery | Your front-row seat to the future of medicine
Joined April 2025
AI is no longer just a tool in the lab — it's becoming the lab. At NVIDIA #GTC, the future of drug discovery was laid bare: computational, agentic, and lightning fast. Here's what you need to know 👇
1
2
2
Following the departure of Lars Fruergaard Jørgensen, Novo Nordisk appoints Maziar Mike Doustdar as the new CEO. Doustdar, currently EVP of international operations, will take the helm on Aug. 7 after the company's half-year report.
1
0
0
AbbVie is reportedly considering a $1B acquisition of Gilgamesh to enhance its neuroscience portfolio. This move complements its strong sales performance with Skyrizi and Rinvoq. Strategic business development in action.
1
0
0
Ultromics raises $55M to expand in the U.S. and improve cardiovascular disease detection accuracy. CEO Ross Upton highlights the focus on new AI modules. Exciting developments ahead!.
1
0
0
This initiative comes as part of a broader effort to address the growing interest in moving away from traditional animal models in research and regulatory processes. 2/2.
0
0
0
A program supported by Big Pharma and the NIH foundation is launching to promote alternatives to animal testing in drug development. 1/2.
1
0
0
A new Caribbean company, Excalipoint, has entered the T-cell engager arena by striking a significant deal with Lepu Biopharma. The $857M agreement includes an initial payment of $10M for two preclinical assets. Stay tuned for developments in this rapidly evolving space.
1
0
0
Baxter faces a stock drop of over 20% post financial forecast cut and infusion pump shipment pause. The company is slowly recovering from Hurricane Helene's impact. A challenging period ahead for Baxter. 📉💼.
1
0
0
The focus is on reducing, replacing, or refining the use of live animals in research. 2/2.
0
0
0
A new initiative, the Validation and Qualification Network, aims to shift drug development away from animal testing. This program, supported by various partners, will review proposals until Dec. 31.
1
0
0
While DCTs offer benefits, challenges in data quality and international implementation remain. Sponsors need robust data architectures to keep up with this evolving landscape. 2/2.
0
0
0
Decentralized Clinical Trials (DCTs) are on the rise, increasing 1.7 times in the USA in 2020. The global market is projected to exceed $21 billion USD by 2030, growing at a 14% CAGR.
2
0
0
🚀 Allogene reports patient death in pivotal trial linked to anti-CD52 mAb, but assures the incident is unrelated to their CAR-T therapy. Trial continues with modified protocol.
1
0
0
RT @davedangond: My latest write up explores the evolution of AI in scientific discovery from the '60s to today. With breakdowns of (IMO)….
0
1
0